Skip to main content

Yeon-A Jo

Yonsei University · 医学

研究室紹介

Professor Yeon-A Jo's research lab specializes in radiation oncology and cancer prognosis, with a focus on optimizing treatment outcomes for head and neck, prostate, and breast cancers. The lab investigates the impact of systemic inflammation, sarcopenia, and inflammatory biomarkers—such as neutrophil/lymphocyte ratio—on survival and treatment response in patients undergoing definitive radiotherapy or chemoradiotherapy. They also explore advanced radiotherapy techniques, including volumetric-modulated arc therapy (VMAT) and brachytherapy, to improve target coverage and organ preservation in complex cases like synchronous bilateral breast cancer and ocular melanoma.

radiation oncologycancer prognosissarcopeniainflammatory biomarkersintensity-modulated radiotherapy

Research Overview

Papers
89
Total Citations
1,345
Papers (5y)
28
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
28total
2022
2023
2024
2025
2026
Citations per year (5y)
263total
20222023202420252026

Selected Papers

15
1
Article|146 citations·2019
Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer
Yeona Cho, Sang Joon Park, Hwa Kyung Byun, Chang Geol Lee, Jaeho Cho, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sinae Kim, Juyoung Park, Hong In Yoon
SJR Q1International Journal of Radiation Oncology*Biology*PhysicsOA
OncologyMedicine
2
Article|95 citations·2018
Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
Yeona Cho, Jun Won Kim, Ki Chang Keum, Chang Geol Lee, Hei Cheul Jeung, Ik Jae Lee
SJR Q2Frontiers in OncologyOA

<b>Purpose:</b> With growing evidence that inflammation and low muscularity play a role in the survival of cancer patients, we evaluated the prognostic implications of sarcopenia with systemic inflammation in patients who underwent definitive chemoradiotherapy (CCRT) for locally advanced head and neck cancer. <b>Materials and Methods:</b> We analyzed 221 patients with head and neck cancer who received definitive CCRT between 2006 and 2015. The skeletal muscle area was measured using a single com

PhysiologyMedicine
3
Article|68 citations·2022
Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy
Yeona Cho, Yejin Kim, Ibrahim Chamseddine, Won Hee Lee, Hye Ryun Kim, Ik Jae Lee, Min Hee Hong, Byung Chul Cho, Chang Geol Lee, Seungryong Cho, Jin Sung Kim, Hong In Yoon
SJR Q1Radiotherapy and OncologyOA
OncologyMedicine
4
Article|68 citations·2016
Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?
Yeona Cho, Jee Suk Chang, Koon Ho Rha, Sung Joon Hong, Young Deuk Choi, Won Sik Ham, Jun Won Kim, Jaeho Cho
SJR Q1PLoS ONEOA

Our data suggest that radiotherapy to the primary tumor was associated with improved OS and BCFFS in metastatic prostate cancer. The results of this study warrant prospective controlled clinical trials of this approach in stage IV prostate cancer patients with limited extent of bone metastasis and good performance status.

Pulmonary and Respiratory MedicineMedicine
5
Article|66 citations·2016
Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients
Yeona Cho, K. H. Kim, Hong In Yoon, G. E. Kim, Yong Bae Kim
SJR Q1Annals of OncologyOA
Obstetrics and GynecologyMedicine
6
Article|47 citations·2018
The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
Yeona Cho, Jun Won Kim, Hong In Yoon, Chang Geol Lee, Ki Chang Keum, Ik Jae Lee
SJR Q1Journal of Clinical MedicineOA

Background: To investigate the prognostic value of pre-treatment neutrophil/lymphocyte ratio (NLR) in patients treated with definitive radiotherapy (RT) for head and neck cancer. Methods: We retrospectively analyzed 621 patients who received definitive RT for nasopharyngeal, oropharyngeal, hypopharyngeal, and laryngeal cancer. An NLR cut-off value of 2.7 was identified using a receiver operating characteristic curve analysis, with overall survival (OS) as an endpoint. Results: The 5-year progres

OncologyMedicine
7
Article|24 citations·2017
Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma
Yeona Cho, Tae Hyung Kim, Jinsil Seong
SJR Q2Strahlentherapie und OnkologieOA
SurgeryMedicine
8
Article|23 citations·2019
Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation
Yeona Cho, Yoon Jin Cho, Won Suk Chang, Jun Won Kim, Won Hoon Choi, Ik Jae Lee
SJR Q1Radiation OncologyOA

We evaluated the optimal radiotherapy (RT) plan for synchronous bilateral breast cancer (SBBC), especially treatment plans including the regional lymph node (LN) area. This study was conducted using 15 patients with SBBC (5 with small breasts, 5 with large breasts, and 5 who underwent a left total mastectomy). The clinical target volume (CTV) was defined as the volume enveloping the bilateral whole breasts/chest wall and left regional LN area. We established the following plans: 1) volumetric-mo

Cancer ResearchBiochemistry, Genetics and Molecular Biology
9
Article|23 citations·2019
Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes
Yeona Cho, Hong In Yoon, Ik Jae Lee, Jun Won Kim, Chang Geol Lee, Eun Chang Choi, Se‐Heon Kim, Ki Chang Keum
SJR Q1Head & NeckOA

BACKGROUND: We aimed to determine the patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers. METHODS: One hundred-fourteen patients with oropharyngeal and oral cancers underwent resection and reconstruction. The local recurrences were classified as "intra-flap" (the recurrent tumor was located in the flap tissue), "marginal" (≤5 mm from the flap anastomosis), and "outside" (in the original tissue and >5 mm from the anastomosis) recurrences. R

OtorhinolaryngologyMedicine
10
Article|13 citations·2017
Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients
Yeona Cho, Jee Suk Chang, Jin Sook Yoon, Sung Chul Lee, Yong Bae Kim, Joo Ho Kim, Ki Chang Keum
SJR Q1Cancer Research and TreatmentOA

<sup>106</sup>Ru brachytherapy showed favorable outcomes in small choroidal melanomas in Korean patients. Although additional local treatment could improve eye-preservation rate for large tumors, other strategies should be considered for disease control.

OphthalmologyMedicine
11
Article|10 citations·2021
Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients
Yeona Cho, Joongyo Lee, Ik Jae Lee, Jun Won Kim, Jong Geol Baek, Dong Min Jung, Byoung Chul Cho, Min Hee Hong, Hye Ryun Kim, Chang Geol Lee, Hong In Yoon
SJR Q1Scientific ReportsOA

We evaluated intracranial failure after hippocampus-avoidance-prophylactic cranial irradiation (HA-PCI) for limited-stage small-cell lung cancer (SCLC). Data of 106 patients who received PCI with 25 Gy were retrospectively reviewed. The patients were divided into two groups based on whether they underwent HA-PCI: the HA-PCI group (n = 48) and the conventional PCI (C-PCI) group (n = 58). Twenty-one patients experienced intracranial failure: 11 and 10 patients in the C-PCI and HA-PCI groups, respe

OncologyMedicine
12
Article|8 citations·2022
Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complications and Early Outcomes
Yeona Cho, Jun Won Kim, Hyung Sun Kim, Joon Seong Park, Ik Jae Lee
SJR Q2Yonsei Medical JournalOA

Trial Registration: Clinical trial registration No. (NCT03273374).

OncologyMedicine
13
Article|7 citations·2012
Cellular Function of RhoGDI-α Mediates the Cycling of Rac1 and the Regulation of Pancreatic Beta Cell Death
Yeona Cho, Kyu Ha Huh, Y.-J. Park, J.H. Do, Dong Jin Joo, Myoung Soo Kim, Yu Seun Kim
SJR Q3Transplantation ProceedingsOA
SurgeryMedicine
14
Article|7 citations·2020
Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
Yeona Cho, Jun Won Kim, Ja Kyung Kim, Kwan Sik Lee, Jung Il Lee, Hyun Woong Lee, Kwang‐Hun Lee, Seung‐Moon Joo, Jin Hong Lim, Ik Jae Lee
SJR Q1CancersOA

Concurrent intra-arterial chemotherapy and radiotherapy (iA-CCRT) can increase the response rate in hepatocellular carcinoma (HCC), but may cause a higher toxicity. We conducted this Phase I study to investigate the dose-limiting toxicity of iA-CCRT for HCC. In total, 52.5 Gy in 25 fractions was prescribed as planning target volume (PTV) 1 at dose level 1. The dose escalation was 0.2 Gy per fraction and up to 2.5 Gy, with 62.5 Gy at level 3. Concurrent intra-arterial 5-fluorouracil was administe

HepatologyMedicine
15
Article|4 citations·2024
Dosimetric Comparison of CPAP and DIBH for Left-sided Breast Cancer Radiation Therapy
Min Seo Choi, Ryeong Hwang Park, Joongyo Lee, Yeona Cho, Jee Suk Chang, Jihun Kim, Jihun Kim, Jin Sung Kim, Jin Sung Kim
SJR Q1Advances in Radiation OncologyOA

PurposeDespite the increasing interest in using continuous positive airway pressure (CPAP) in radiation therapy (RT), direct comparisons with the more widely used deep inspiration breath-hold (DIBH) have been limited. This planning study aimed to offer comprehensive geometric and dosimetric evidence by comparing CPAP and DIBH-based RT plans.Materials and MethodsA retrospective data set of 35 patients with left-sided breast cancer with planning computed tomography scans under three breathing cond

RadiationPhysics and Astronomy

Research Areas

OncologyCancer ResearchSurgeryRadiationPulmonary and Respiratory MedicinePhysiology

Yeon-A Joの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。